Boston, MA, and Dossenheim, Germany, March 16, 2016 -- WorldCare Clinical (WCC), a leading provider of imaging services for clinical trials, today announced its collaboration with Mint Medical, an image processing company with analysis software which improves the accuracy and productivity of radiology reads in oncology studies.
WCC has integrated Mint Medical's mint Lesion™ software into WCC's workflow platform to ensure seamless flow of images and data in a single system. The system now provides WCC's reviewers and sponsors with the capabilities of Mint Medical's advanced analysis tool, with the ease-of-use of WCC's industry-leading image management workflow platform.
"The combination of WorldCare's scientific, technological, and operational expertise with Mint Medical's mint Lesion™ analysis software creates the market-leading offering to help sponsors achieve their goals in Oncology clinical trials," stated Aaron Timm, CEO of WorldCare Clinical. "We are excited about the opportunities that arise when combining the flexibility of mint Lesion™ with the expert knowledge of WorldCare," concluded Dr. Matthias Baumhauer, CEO of Mint Medical.
In addition to its early phase work, WCC has performed more than 40 Phase III Oncology clinical trials.
About WorldCare Clinical
WorldCare Clinical is a global imaging CRO that employs scientific expertise, innovative technology, and operational excellence to maximize the precision and accuracy of a blinded independent central review of Phase I – IV clinical trial data. The company has worked with thousands of sites in more than 60 countries. WCC's robust technology platform processes over 250 million images annually (CT, MRI, X-Ray, Echo, US, PET). Originally founded in 1992 by the Massachusetts General Hospital (MGH) Department of Radiology, WorldCare continues to maintain a strategic relationship with the Harvard Hospital System as well as other leading academic institutions.
About Mint Medical
Mint Medical is a medical imaging software company providing leading solutions for the standardization of radiological read procedures and structured reporting. Mint Medical is a spin-off of the German Cancer Research Center and relies on a global network of cancer centers and health care institutions that apply Mint Medical's mint Lesion™ in clinical routine and clinical research.
The software solution mint Lesion™ offers context-assisted, explicit reader guidance that simplifies the radiological read and assures full adherence to criteria and further particular imaging charter demands. mint Lesion™ also offers flexible workflow management capabilities that can be custom-tailored per software configuration. mint Lesion™ has received clearance and approval by CE and FDA (510k) and has been designed to meet all requirements defined in FDA CFR Part 11, GxP, and HIPAA. Applied for all phases of clinical research, mint Lesion™ has generated data for phase III trials that has been accepted by FDA.
For more information on WCC's services, please visit our website at www.wcclinical.com or contact:
Executive Vice President
For more information on Mint Medical and mint Lesion™, please visit www.mintmedical.com or contact:
Director Marketing and Sales